Allspring Global Investments
NGM

Allspring Global Investments’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Allspring Global Investments’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-16,468
Closed -$17.6K – 2827
2023
Q3 		$17.6K Buy
16,468
+8,703
+112% +$18K ﹤0.01% 2532
2023
Q2 		$20.1K Buy
+7,765
New +$27.7K ﹤0.01% 2462
2022
Q3 		– Sell
-569
Closed -$7K – 2972
2022
Q2 		$7K Sell
569
-8,912
-94% -$123K ﹤0.01% 2603
2022
Q1 		$144K Buy
9,481
+939
+11% +$14.6K ﹤0.01% 2669
2021
Q4 		$151K Buy
+8,542
New +$164K ﹤0.01% 2696

Other funds holding NGM

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allspring Global Investments's NGM Position: Q4 2023 in Review

Allspring Global Investments sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q4 2023, closing a stake of 16,468 shares — an estimated $17.6K sold.

Allspring Global Investments first reported a position in NGM in Q4 2021 and held it in 5 quarters. The position peaked at $151K in Q4 2021. 83 funds tracked by Wall St. Rank hold NGM as of Q4 2023.

  • Allspring Global Investments reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 16,468 NGM Biopharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $17.6K.
  • Allspring Global Investments first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Allspring Global Investments's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $151K in Q4 2021.
  • 83 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.